## **Core Concept**
The question revolves around the genetic basis of early-onset cardiovascular disease, specifically focusing on familial hypercholesterolemia (FH), a condition characterized by very high levels of low-density lipoprotein cholesterol (LDL-C) leading to premature atherosclerotic cardiovascular disease (ASCVD).

## **Why the Correct Answer is Right**
The correct answer, **LDL receptor**, is implicated in Familial Hypercholesterolemia (FH), an autosomal dominant disorder. FH is caused by mutations in the gene encoding the LDL receptor, which is crucial for removing LDL cholesterol (often referred to as "bad" cholesterol) from the bloodstream. A deficiency or dysfunction of this receptor leads to markedly elevated levels of LDL cholesterol, resulting in premature atherosclerotic cardiovascular disease. The patient's presentation with angina at a young age and a family history of cardiovascular disease supports this diagnosis.

## **Why Each Wrong Option is Incorrect**
- **Option A: Apolipoprotein B** - While mutations in the APOB gene can cause a similar condition to FH, known as familial defective apolipoprotein B-100, it is less common than LDL receptor mutations. This condition also leads to elevated LDL cholesterol levels but through a different mechanism.
- **Option B: PCSK9** - PCSK9 (proprotein convertase subtilisin/kexin type 9) gene mutations can cause familial hypercholesterolemia, but typically, gain-of-function mutations lead to increased LDL receptor degradation and thus elevated LDL levels, whereas loss-of-function mutations are associated with lower LDL levels and reduced cardiovascular risk.
- **Option D: Endothelial Nitric Oxide Synthase (eNOS)** - eNOS is involved in vascular tone regulation through the production of nitric oxide. While important for cardiovascular health, mutations in the eNOS gene are more commonly associated with conditions like hypertension or atherosclerosis susceptibility rather than causing isolated marked hypercholesterolemia.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that Familial Hypercholesterolemia (FH) can be diagnosed using the Dutch Lipid Clinic Network criteria, which includes a points system based on LDL cholesterol levels, family history, and genetic testing. Early diagnosis and treatment of FH, including statins, ezetimibe, PCSK9 inhibitors, and LDL apheresis, can significantly reduce the risk of premature ASCVD.

## **Correct Answer:** . **LDL receptor**